“School of Cognitive”

Back to Papers Home
Back to Papers of School of Cognitive

Paper   IPM / Cognitive / 17849
School of Cognitive Sciences
  Title:   Limits on using the clock drawing test as a measure to evaluate patients with neurological disorders
  Author(s): 
1.  R. Heyrani
2.  A. Sarabi-Jamab
3.  J. Grafman
4.  N. Asadi
5.  S. Soltani
6.  FS. Mirfazeli
7.  M. Almasi-Dooghaei
8.  SV. Shariat
9.  A. Jahanbakhshi
10.  T. Khoeini
11.  MT. Joghataei
  Status:   Published
  Journal: BMC Neurology
  No.:  1
  Vol.:  22
  Year:  2022
  Pages:   509
  Supported by:  IPM
  Abstract:
Background: The Clock Drawing Test (CDT) is used as a quick-to-conduct test for the diagnosis of dementia and a screening tool for cognitive impairments in neurological disorders. However, the association between the pattern of CDT impairments and the location of brain lesions has been controversial. We examined whether there is an association between the CDT scores and the location of brain lesions using the two available scoring systems. Method: One hundred five patients with brain lesions identified by CT scanning were recruited for this study. The Montreal Cognitive Assessment (MoCA) battery including the CDT were administered to all partcipants. To score the CDT, we used a qualitative scoring system devised by Rouleau et al. (1992). For the quantitative scoring system, we adapted the algorithm method used by Mendes-Santos et al. (2015) based on an earlier study by Sunderland et al. (1989). For analyses, a machine learning algorithm was used. Results: Remarkably, 30% of the patients were not detected by the CDT. Quantitative and qualitative errors were categorized into different clusters. The classification algorithm did not differentiate the patients with traumatic brain injury 'TBI' from non-TBI, or the laterality of the lesion. In addition, the classification accuracy for identifying patients with specific lobe lesions was low, except for the parietal lobe with an accuracy of 63%. Conclusion: The CDT is not an accurate tool for detecting focal brain lesions. While the CDT still is beneficial for use with patients suspected of having a neurodegenerative disorder, it should be cautiously used with patients with focal neurological disorders.

Download TeX format
back to top
scroll left or right